ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027

ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027

  • July 2019 •
  • 131 pages •
  • Report ID: 5791594 •
  • Format: PDF
KEY FINDINGS
The Asia Pacific Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.82% during the forecast period of 2019-2027.

MARKET INSIGHTS
The countries like China, India, Japan, South Korea and Australia are considered fr the market analysis.Factors such as limited resource usability coupled with increasing prevalence rates, and technological advancements, are the major drivers in Asia Pacific segment of point of care testing market which is expected to witness the fastest growth over the forecast period.

Japan is one of the largest market for in vitro diagnostics and the popularity of point of care testing has increased due to the focus towards benefits of in vitro diagnostics.

COMPETITIVE INSIGHTS
F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Bio-Rad Laboratories, Inc., Biomérieux SA, Danaher Corporation, Abbott, Chembio Diagnost ICS Systems, Inc., Becton Dickinson and Company, Gene POC, Trinity Biotech, Siemens Healthineers, Trivitron Healthcare, Sight Diagnostics Ltd., Ortho Clinical Diagnostics, and Cardinal Health Inc. are the major companies.

Companies mentioned
1. ABBOTT
2. BECTON DICKINSON AND COMPANY
3. BIOMÉRIEUX SA
4. BIO-RAD LABORATORIES, INC.
5. CARDINAL HEALTH INC.
6. CHEMBIO DIAGNOST ICS SYSTEMS, INC.
7. DANAHER CORPORATION
8. GENE POC
9. F. HOFFMANN-LA ROCHE LTD.
10. ORTHO CLINICAL DIAGNOSTICS
11. QUEST DIAGNOSTICS INC.
12. SIEMENS HEALTHINEERS
13. SIGHT DIAGNOSTICS LTD.
14. THERMO FISHER SCIENTIFIC INC.
15. TRINITY BIOTECH
16. TRIVITRON HEALTHCARE